Annabis Medical s.r.o Sustainability Profile
Annabis Medical s.r.o., a leading player in the Czech Republic's medical cannabis industry, is headquartered in CZ and operates extensively across Europe. Founded in 2015, the company has rapidly established itself as a pioneer in the cultivation and distribution of high-quality cannabis products, focusing on both medicinal and therapeutic applications. Specialising in a range of unique cannabis-based products, Annabis Medical s.r.o. is renowned for its commitment to quality and innovation. Their offerings include oils, capsules, and topical solutions, all crafted to meet stringent regulatory standards. The company has achieved significant milestones, including partnerships with healthcare professionals and research institutions, solidifying its position as a trusted name in the market. With a strong emphasis on patient care and education, Annabis Medical continues to lead the way in advancing the understanding and use of medical cannabis in Europe.
DitchCarbon Score
How does Annabis Medical s.r.o's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Annabis Medical s.r.o's score of 0 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Annabis Medical s.r.o, headquartered in the Czech Republic (CZ), currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Canopy Growth Corporation, which means that any emissions data or climate commitments may be inherited from this parent organization. As of now, Annabis Medical s.r.o has not established any documented reduction targets or climate pledges. The absence of specific emissions figures indicates a potential gap in their climate reporting, which is crucial for transparency and accountability in addressing climate change. The company’s climate initiatives and commitments may be influenced by the broader strategies of Canopy Growth Corporation, which is known for its sustainability efforts. However, without direct data or specific targets from Annabis Medical s.r.o, it is challenging to assess their individual impact or commitments in the context of carbon emissions. In summary, while Annabis Medical s.r.o is part of a larger corporate family with potential sustainability initiatives, it currently lacks specific emissions data and defined climate commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | |
|---|---|
| Scope 1 | 36,548,000 |
| Scope 2 | 22,434,000 |
| Scope 3 | - |
How Carbon Intensive is Annabis Medical s.r.o's Industry?
How Carbon Intensive is Annabis Medical s.r.o's Location?
Annabis Medical s.r.o's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Annabis Medical s.r.o has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
